UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...
They are large, intelligent, and remarkably social—elephants fascinate many people. With their calm demeanor, they impress at first glance. But it’s not just their appearance; their longevity is also ...